Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5289996
Max Phase: Preclinical
Molecular Formula: C35H43N7O7S
Molecular Weight: 705.84
Associated Items:
ID: ALA5289996
Max Phase: Preclinical
Molecular Formula: C35H43N7O7S
Molecular Weight: 705.84
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(N)nc3c2ncn3C(=O)NCc2cccc([N+](=O)[O-])c2)[C@@]2(C)C3C(=O)CC[C@@]3(CC[C@H]2C)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C35H43N7O7S/c1-6-33(4)15-24(34(5)19(2)10-12-35(20(3)28(33)45)13-11-23(43)27(34)35)49-25(44)17-50-30-26-29(39-31(36)40-30)41(18-38-26)32(46)37-16-21-8-7-9-22(14-21)42(47)48/h6-9,14,18-20,24,27-28,45H,1,10-13,15-17H2,2-5H3,(H,37,46)(H2,36,39,40)/t19-,20+,24-,27?,28+,33-,34+,35+/m1/s1
Standard InChI Key: SJDHYRJHOJNBFL-QEFIFENASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 705.84 | Molecular Weight (Monoisotopic): 705.2945 | AlogP: 5.07 | #Rotatable Bonds: 8 |
Polar Surface Area: 205.46 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: | CX Basic pKa: 1.54 | CX LogP: 4.46 | CX LogD: 4.46 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.07 | Np Likeness Score: 0.30 |
1. Yong C, Yu J, Wu C, Zhang X, Li Y, Xie C, He X, Liu D, Wang Z, Lai P, Zhang Y.. (2023) Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives., 14 (6): [PMID:37312858] [10.1021/acsmedchemlett.3c00004] |
Source(1):